BRPI0822661A2 - Compostos oticamente puros para eficiência terapêutica melhorada - Google Patents
Compostos oticamente puros para eficiência terapêutica melhoradaInfo
- Publication number
- BRPI0822661A2 BRPI0822661A2 BRPI0822661-0A BRPI0822661A BRPI0822661A2 BR PI0822661 A2 BRPI0822661 A2 BR PI0822661A2 BR PI0822661 A BRPI0822661 A BR PI0822661A BR PI0822661 A2 BRPI0822661 A2 BR PI0822661A2
- Authority
- BR
- Brazil
- Prior art keywords
- optically pure
- pure compounds
- improved therapeutic
- therapeutic efficiency
- efficiency
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2008/053469 WO2009141687A1 (en) | 2008-05-22 | 2008-05-22 | New optically pure compounds for improved therapeutic efficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0822661A2 true BRPI0822661A2 (pt) | 2015-06-30 |
Family
ID=40957783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0822661-0A BRPI0822661A2 (pt) | 2008-05-22 | 2008-05-22 | Compostos oticamente puros para eficiência terapêutica melhorada |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9243030B2 (pt) |
| EP (1) | EP2291390B1 (pt) |
| JP (1) | JP5548866B2 (pt) |
| CN (1) | CN102037005B (pt) |
| AU (1) | AU2008356840B2 (pt) |
| BR (1) | BRPI0822661A2 (pt) |
| CA (1) | CA2724818C (pt) |
| WO (1) | WO2009141687A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2900341B1 (fr) | 2006-04-27 | 2012-09-14 | Centre Nat Rech Scient | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer |
| AU2008356840B2 (en) | 2008-05-22 | 2013-05-16 | Centre National De La Recherche Scientifique (Cnrs) | New optically pure compounds for improved therapeutic efficiency |
| BR112013008037A2 (pt) | 2010-10-04 | 2019-09-24 | Centre Nat Rech Scient | compostos multivalentes como tratamento antibiótico |
| RU2458663C1 (ru) * | 2010-12-27 | 2012-08-20 | Общество с ограниченной ответственностью предприятие "Репер НН" | Трансплантат для склеропластики |
| CN104356221B (zh) * | 2014-10-24 | 2018-06-26 | 杭州阿诺生物医药科技股份有限公司 | 一种制备培西加南的方法 |
| WO2017079821A1 (en) | 2015-11-11 | 2017-05-18 | Encycle Therapeutics, Inc. | Fragment synthesis of cyclic peptides |
| JP7035044B2 (ja) | 2016-11-11 | 2022-03-14 | ジーランド ファーマ エー／エス | α４β７インテグリンを標的とする環状ペプチド多量体 |
| IL270465B (en) | 2017-05-10 | 2022-09-01 | Encycle Therapeutics Inc | Cyclic peptides targeting alpha4beta7 integrin |
| CN109381362A (zh) * | 2018-12-19 | 2019-02-26 | 浙江神首生物科技有限公司 | 一种焕活生机修复乳液及其制备方法 |
| WO2022223544A1 (en) | 2021-04-19 | 2022-10-27 | Centre National De La Recherche Scientifique (Cnrs) | COMBINATION THERAPY OF NUCANT AND mTOR INHIBITORS FOR TREATING CANCER |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| FR2437213A1 (fr) | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
| FR2719049B1 (fr) | 1994-04-22 | 1996-06-14 | Pasteur Institut | Multireprésentation d'un analogue peptidique du substrat de la DPPIV, notamment de type KPR, afin d'inhiber l'entrée du HIV dans les cellules. |
| US5891737A (en) | 1995-06-07 | 1999-04-06 | Zymogenetics, Inc. | Combinatorial non-peptide libraries |
| US6121236A (en) | 1998-03-24 | 2000-09-19 | The Children's Medical Center Corporation | Multivalent ligands which modulate angiogenesis |
| ATE375358T1 (de) | 1999-04-08 | 2007-10-15 | Antisoma Res Ltd | Antiproliferative aktivität von g-reichen oligonukleotiden und verfahren um sie zur bindung an nukleotin zu verwenden |
| US6783952B1 (en) | 1999-09-16 | 2004-08-31 | Warner-Lambert Company | Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same |
| FR2809960B1 (fr) | 2000-06-07 | 2004-04-23 | Pasteur Institut | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante |
| FR2828207B1 (fr) | 2001-08-02 | 2004-12-24 | Centre Nat Rech Scient | Milieux de reaction pour l'activite thymidylate synthase de la thyx |
| US20040002457A1 (en) | 2002-03-12 | 2004-01-01 | Hovanessian Ara V. | Inhibition of virus anchorage by RGG domain of a cell surface-expressed protein, polynucleotide coding for said RGG domain, therapeutic uses thereof by inhibition of microorganism or protein ligand binding to the cell-surface-expressed protein |
| US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| US7357928B2 (en) | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
| FR2840307B1 (fr) | 2002-05-30 | 2006-07-07 | Centre Nat Rech Scient | Nouvelles molecules multimeriques, leur procede de preparation, et leur utilisation pour la preparation de medicaments |
| TW200504210A (en) | 2003-07-30 | 2005-02-01 | Chin-Tarng Lin | A nucleolin antisense inhibiting growth of cancer cell |
| US20080234464A1 (en) | 2005-04-22 | 2008-09-25 | Hisafumi Ikeda | Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same |
| FR2900341B1 (fr) | 2006-04-27 | 2012-09-14 | Centre Nat Rech Scient | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer |
| DE602007010459D1 (de) | 2007-09-04 | 2010-12-23 | Inst Nat Sante Rech Med | Verwendung von Verbindungen, die die EF-Tu-Nucleolin Wechselwirkung vehindern, zur Verhinderung oder Behandlung von Tularämie |
| AU2008356840B2 (en) | 2008-05-22 | 2013-05-16 | Centre National De La Recherche Scientifique (Cnrs) | New optically pure compounds for improved therapeutic efficiency |
| BR112013008037A2 (pt) | 2010-10-04 | 2019-09-24 | Centre Nat Rech Scient | compostos multivalentes como tratamento antibiótico |
-
2008
- 2008-05-22 AU AU2008356840A patent/AU2008356840B2/en active Active
- 2008-05-22 WO PCT/IB2008/053469 patent/WO2009141687A1/en active Application Filing
- 2008-05-22 BR BRPI0822661-0A patent/BRPI0822661A2/pt not_active IP Right Cessation
- 2008-05-22 CN CN200880129310.6A patent/CN102037005B/zh active Active
- 2008-05-22 US US12/993,427 patent/US9243030B2/en active Active
- 2008-05-22 EP EP08807467.9A patent/EP2291390B1/en active Active
- 2008-05-22 JP JP2011510059A patent/JP5548866B2/ja active Active
- 2008-05-22 CA CA2724818A patent/CA2724818C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009141687A1 (en) | 2009-11-26 |
| EP2291390A1 (en) | 2011-03-09 |
| CN102037005A (zh) | 2011-04-27 |
| JP5548866B2 (ja) | 2014-07-16 |
| AU2008356840B2 (en) | 2013-05-16 |
| CN102037005B (zh) | 2017-03-29 |
| CA2724818C (en) | 2015-06-16 |
| US9243030B2 (en) | 2016-01-26 |
| AU2008356840A1 (en) | 2009-11-26 |
| JP2011523418A (ja) | 2011-08-11 |
| US20110201559A1 (en) | 2011-08-18 |
| CA2724818A1 (en) | 2009-11-26 |
| EP2291390B1 (en) | 2014-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0822661A2 (pt) | Compostos oticamente puros para eficiência terapêutica melhorada | |
| SMT201600045B (it) | Composti tetraciclinici c7-fluoro sostituiti | |
| DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
| BRPI0920707A2 (pt) | compostos | |
| DK2242759T3 (da) | Forbindelser | |
| BRPI0821086A2 (pt) | Compostos inseticidas | |
| ES2397671T8 (es) | Procedimiento para preparar voriconazol | |
| BRPI0811264A2 (pt) | Compostos | |
| BRPI0813670A2 (pt) | Compostos para tratamento | |
| DK2297162T3 (da) | Forbindelser | |
| BRPI0917866A2 (pt) | métodos para intensificar o metabolismo energético | |
| BRPI0916432A2 (pt) | compostos | |
| DK2271618T3 (da) | Farmaceutiske forbindelser | |
| BRPI0809996A2 (pt) | Compostos | |
| IT1396626B1 (it) | Asse di azionamento | |
| BRPI0917718A2 (pt) | calçado | |
| BRPI0922152A2 (pt) | Compostos | |
| BRPI0909764A2 (pt) | compostos terapêuticos | |
| BRPI0906879A2 (pt) | Compostos terapêuticos | |
| BRPI0922134A2 (pt) | Compostos | |
| BRPI0912193A2 (pt) | compostos terapêuticos. | |
| ES1065835Y (es) | Caperuza para cetreria | |
| ES1068587Y (es) | Asa para garrafas | |
| ES1067516Y (es) | Horma tipo palillo para zapatos | |
| DK2257548T3 (da) | Terapeutiske forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: C07K 5/068 (2006.01), C07K 7/06 (2006.01), A61K 38 |
|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2516 DE 26-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |